899 followers
Rounded with #Prevention fellow - nice to be sent a great review in @JACCJournals on Therapies in #Diabetes by @NYUCVDPrevent colleagues @JDNewmanMDMPH and Dr Schwartzbard and #Cardiology fellow Dr Wilcox https://t.co/XlhRt01xZh
602 followers
RT @SemergenGTDM: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of…
575 followers
RT @SemergenGTDM: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of…
2,283 followers
RT @SemergenGTDM: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of…
1,398 followers
RT @SemergenGTDM: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of…
116 followers
RT @SemergenGTDM: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of…
2,472 followers
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of Cardiology https://t.co/kX9o5XaN31
168 followers
RT @edi0029: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar https://t.co/V7LuCtQ9AW htt…
239 followers
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar https://t.co/V7LuCtQ9AW https://t.co/u5NHyaAZ4N
1,189 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
1,043 followers
597 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
2,438 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
246 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
582 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
7,660 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
276 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
136 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
1,748 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
764 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
387 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
113 followers
RT @smexcardiologia: En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos c…
406 followers
Individualizar es la clave, pero definitivamente los GLP1 de aplicación semanal han revolucionado el apego al tratamiento por nuestros pacientes. #SocMexCardio
14,929 followers
En diabetes y enfermedad cardiovascular, Que estrategia Farmacológica es la mejor para mi paciente? Existen fármacos con beneficios especiales de acuerdo al contexto de nuestros pacientes. https://t.co/8Z78LEKeSv #SocMexCardio @rodrigogopar @mitrehit @Lui
812 followers
Another good overview: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists https://t.co/kf9v9W1j0b
598 followers
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists https://t.co/Bc45SnvkI5
1,138 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
1,327 followers
【総説】糖尿病薬、メトホルミンからSGLT2阻害薬およびGLP1受容体作動薬まで https://t.co/LHMrZCeQzW
583 followers
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of Cardiology https://t.co/UW0TEpZ9QC
126 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
2,889 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
5,949 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
1,015 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
231 followers
366 followers
516 followers
283 followers
113 followers
387 followers
21,453 followers
3 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
3 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
1,343 followers
RT @smexcardiologia: En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQi…
1,189 followers
RT @smexcardiologia: En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQi…
4,148 followers
RT @smexcardiologia: En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQi…
670 followers
RT @smexcardiologia: En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQi…
314 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
140 followers
RT @smexcardiologia: En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQi…
1,748 followers
RT @smexcardiologia: En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQi…
14,929 followers
En el último número de @JACCJournals , se presenta una revisión histórica del tratamiento para DM. https://t.co/AzTbQirl9L #SocMexCardio @AmadaAlvarez @CarlosguizarS @drgianma @Julio_Farjat @jpsanchezluna @jcdelafuentem @rodrigogopar @mitrehit @LuisBaeza1
7,538 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
86 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
269 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
484 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
145 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
549 followers
@NYUCVDPrevent @NYUCVRC
53 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
1,364 followers
457 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
104 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
1,863 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
7,538 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
549 followers
RT @JACCJournals: Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes…
105,085 followers
Pharmacologic agents are an important tool in the arsenal for patients with #diabetes, but they also impact #CVD outcomes. Here’s what you need to know: https://t.co/gdY3JAwQDd #JACC @JDNewmanMD https://t.co/rlGdWrJ0CD
280 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
86 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
33 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
293 followers
126 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
311 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
84 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
948 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
476 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
2,393 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
80 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
2,438 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
287 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
102 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
821 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
107 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
169 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
2,673 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
549 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
423 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
14 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
1,364 followers
243 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
575 followers
RT @JACCJournals: In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and thei…
105,085 followers
In a new #JACC focus seminar, @JDNewmanMD et al. review diabetic agents such as metformin and #SGLT2 inhibitors, and their effect on #CVD outcomes. https://t.co/gdY3JAwQDd #diabetes https://t.co/FnHLlfzg0p
751 followers
"Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists" (JACC 2020) - "These medications are becoming essential tools for cardioprotection for patients with diabetes and CVD" - https://t.co/mQ1h2DS7Tz https://t.co/iHQc7EbID8
104 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
203 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
583 followers
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists | JACC: Journal of the American College of Cardiology https://t.co/UW0TEpZ9QC
801 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
3,601 followers
PODCAST: Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists https://t.co/l24s7NABoj
734 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
366 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
4,845 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
7,660 followers
RT @ValleAlfonso: ▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR
21,453 followers
▶️https://t.co/cxj6Igfoc7 via @JACCJournals FOCUS SEMINAR